Executive Profile

Steven S. Gillis M.D., Ph.D. Executive Chairman, VLST Corporation

Age	Total Calculated Compensation	This person is connected to 20 Board Members in 20 different organizations across 23 different industries. See Board Relationships
59	--

Background

Dr. Steven S. Gillis, M.D., Ph.D., Steve, serves as a Managing Director at ARCH Venture Partners, L.P, since 2006. He is focused on the evaluation of new life science technologies and also on the development and growth of ARCH's biotechnology portfolio companies. Dr. Gillis joined ARCH Venture Partners as a Venture Partner in 2005. He has expertise in biotechnology, pharmaceuticals, and vaccines. Dr. Gillis Co-Founder and Director and served as the Chairman and Chief ... Executive Officer at Corixa Corp. since October 1994. He served as the President at Corixa Corp. from 1994 to February 1999 and Chairman since January of 1999. He served as the Chairman and Chief Executive Officer of GenQuest, Inc. Dr. Gillis co-founded and served as an Executive Vice President and a Director of Research and Development from 1981 to 1994 and Acting Chief Executive Officer and the Chairman of Immunex from 1993 to 1994 at Immunex Corporation. From 1990 to 1994, he served as the Chief Executive Officer and President of Immunex Research and Development Corporation and Chief Scientific Officer of Immunex. He also served as Interim Chief Executive Officer following Immunex’s majority purchase by American Cyanamid. He served as an Acting President of Theraclone Sciences, Inc. He served as an Acting President and Executive Chairman of Emergent Product Development Seattle, LLC since November 16, 2009. He served as an Interim Chief Executive Officer of Ikaria, Inc. and its Acting President from August 2006 to May 2007. Dr. Gillis serves as the Chairman of Qwell Pharmaceuticals Inc., Spaltudaq and Lycera Corporation. He serves as Chairman and Director of VentiRx Pharmaceuticals Inc. He serves as an Executive Chairman and Director of VLST Corporation. He serves as the Chairman and Director at PhaseRx Inc. and Theraclone Sciences, Inc. He served as an Executive Chairman of Surface Logix, Inc. since May 2008. He serves as Board Observer at Permeon Biologics, Inc. He has been a Non-Executive Director of Shire Plc since October 1, 2012. He serves as a Director of Magen BioSciences, Inc. Dr. Gillis has been a Director of Migenix Inc., (Formerly Micrologix Inc.) since August 1996 and Genesis Research & Development Corporation Limited since December 02, 1993. He has been a Director of Allozyne, Inc. since October 2007. He serves as a Director at VBI Vaccines Inc., Groove Biopharma Corporation, Acylin Therapeutics Inc., Micrologix Biotech Inc., Oncofactor Corporation, Accelerator Corporation, Variation Biotechnologies Inc., and Pulmatrix Inc. He has been a Director of bluebird bio, Inc. since April 2011. He serves as a Member of Scientific Advisory Board at MedGenesis Therapeutix Inc. He was a Director and Chairman of Trubion Pharmaceuticals (TRBN) and he led its acquisition by Emergent BioSolutions in the fall of 2010. He served as a Director of Koronis Pharmaceuticals, Inc. since 1993 and Metro Vancouver Properties Corp. from August 1996 to August 11, 2008. He served as a Director at Rosetta Inpharmatics Inc. and Rosetta Inpharmatics LLC since June 1997. He served as a Director of Limerick BioPharma, Inc. He served as a Director of Emergent Product Development Seattle, LLC since January 2006 and its Lead director from February 02, 2009 to November 16, 2009. He is an immunologist by training with over 300 peer-reviewed publications in the areas of molecular and tumor immunology. Dr. Gillis is credited as being a pioneer in the field of cytokines and cytokine receptors, directing the development of multiple marketed products including Leukine, (GM-CSF), Prokine (IL-2) and Enbrel (soluble TNF receptor-Fc fusion protein) as well as the regulatory approval of Bexxar (radiolabeled anti-CD20). Dr. Gillis holds a Ph.D. in Biological Sciences from Dartmouth College and graduated from Williams College with a B.A. in Biology and English.

Corporate Headquarters 307 Westlake Avenue North Seattle, Washington 98109 United States Phone: 206-262-5500 Fax: 206-262-5599 Board Members Memberships Co-Founder, Chairman, and Chief Executive Officer Immunex Corporation Chairman and Chief Executive Officer GenQuest, Inc. Executive Chairman Surface Logix, Inc. Director Accelerator Corporation Executive Chairman VLST Corporation Chairman Theraclone Sciences, Inc. Director Magen BioSciences, Inc. Director Pulmatrix, Inc. Chairman Lycera Corporation Director VBI Vaccines Inc Chairman VentiRx Pharmaceuticals, Inc. Chairman PhaseRx, Inc. Former Director Limerick BioPharma, Inc. Director Groove Biopharma Corporation Chairman Qwell Pharmaceuticals, Inc. Director Acylin Therapeutics, Inc. Director Oncofactor Corporation Director Celdara Medical, LLC 1993-N/A Former Director Koronis Pharmaceuticals, Inc. 1993-Present Non-Executive Director, Member of Remuneration Committee and Member of Audit Committee Genesis Research & Development Corp. Ltd. 1994-N/A Co-Founder, Chief Executive Officer, and Chairman Corixa Corporation 1996-2008 Former Director, Member of Special Committee and Member of Compensation Committee Metro Vancouver Properties Corp., Prior to Merger with MPW Properties Partnership 1997-Present Director Rosetta Inpharmatics LLC 2006-N/A Executive Chairman and Acting President Emergent Product Development Seattle, LLC 2007-Present Director Allozyne, Inc. 2011-Present Director and Chairman of Audit Committee bluebird bio, Inc. 2012-Present Non-Executive Director, Member of Remuneration Committee and Member of Science & Technology Committee Shire plc Education PhD Dartmouth College BA Williams College Other Affiliations Arch Venture Partners, L.P. Corixa Corporation bluebird bio, Inc. Immunex Corporation Rosetta Inpharmatics LLC GenQuest, Inc. Shire plc Metro Vancouver Properties Corp., Prior to Merger with MPW Properties Partnership Surface Logix, Inc. Koronis Pharmaceuticals, Inc. Genesis Research & Development Corp. Ltd. Dartmouth College Williams College Accelerator Corporation Emergent Product Development Seattle, LLC Theraclone Sciences, Inc. Ikaria, Inc. Allozyne, Inc. Magen BioSciences, Inc. Pulmatrix, Inc. MedGenesis Therapeutix Inc. Lycera Corporation VBI Vaccines Inc VentiRx Pharmaceuticals, Inc. PhaseRx, Inc. Limerick BioPharma, Inc. Groove Biopharma Corporation Qwell Pharmaceuticals, Inc. Acylin Therapeutics, Inc. Permeon Biologics, Inc. Oncofactor Corporation Celdara Medical, LLC The W Fund

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.